The rapid development of COVID-19 vaccines was made possible through a combination of factors. Firstly, the use of advanced technologies such as mRNA allowed for faster design and production. Secondly, substantial funding from governments and private entities accelerated research and clinical trials. Finally, global collaboration and streamlined regulatory processes enabled quicker approval and deployment.
